Surgery for renal cell cancer extending into the inferior vena cava - Evaluation of survival and perioperative complications using a standardized classification system

BJU International

Volumn 108, Issue 9, 2011, Pages 1439-1443

  Zastrow, Stefan ^a   Leike, Steffen ^a   Oehlschläger, Sven ^a   Grimm, Marc Oliver ^a   Wirth, Manfred ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Clavien Dindo system; kidney cancer; vena cava thrombus

Indexed keywords

SORAFENIB; SUNITINIB;

AGED; ARTICLE; BRONCHOPNEUMONIA; BYPASS SURGERY; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLAVIEN DINDO CLASSIFICATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INFERIOR CAVA VEIN; INFERIOR CAVA VEIN OBSTRUCTION; KIDNEY CARCINOMA; LIVER INJURY; MAINTENANCE OF RESPIRATION AND CIRCULATION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE COMPLICATION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLEEN INJURY; STANDARD; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; VEIN THROMBOSIS; WOUND INFECTION;

AGED; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; NEPHRECTOMY; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBECTOMY; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 80055016444     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10289.x     Document Type: Article

References (29)

1. Novick AC, Kaye MC, Cosgrove DM, et al,. Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg 1990; 212: 472-6; discussion 476-7
2. Ciancio G, Soloway M, Livingstone AS,. The increasing use of liver transplantation surgical techniques in the management of renal and nonrenal cancer with or without Inferior Vena Cava Tumor Thrombus. World J Surg 2009; 33: 1328-9
3. Shuch B, Riggs SB, LaRochelle JC, et al,. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int 2008; 102: 692-6
4. Karakiewicz PI, Suardi N, Jeldres C, et al,. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 2008; 53: 845-8 (Pubitemid 351273883)
5. Staehler M,. Re: Karakiewicz PI, Suardi N, Jeldres C et al. Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 2008; 53: 845-8. Eur Urol 2008; 54: 950-1; author reply 951-3
6. Robert G, Gabbay G, Bram R, et al,. Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma. Eur Urol 2009; 55: 1477-80
7. Neves RJ, Zincke H,. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987; 59: 390-5 (Pubitemid 17070063)
8. Ciancio G, Livingstone AS, Soloway M,. Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol 2007; 51: 988-94; discussion 994-5
9. Clavien PA, Barkun J, de Oliveira ML, et al,. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96
10. Moch H, Artibani W, Delahunt B, et al,. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 2009; 56: 636-43
11. Shuch B, Larochelle JC, Onyia T, et al,. Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol 2009; 181: 492-8; discussion 498-9
12. Kaplan S, Ekici S, Doǧan R, Demircin M, Ozen H, Paşaoǧlu I,. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Am J Surg 2002; 183: 292-9 (Pubitemid 34273989)
13. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H,. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004; 94: 33-41 (Pubitemid 38980305)
14. Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM,. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007; 69: 1054-8 (Pubitemid 46891594)
15. Facciuto ME, Singh MK, Rocca JP, et al,. Benefits of liver transplantation surgical techniques in the management of extensive retroperitoneal tumors. World J Surg 2008; 32: 2403-7
16. Kirkali Z,. A critical analysis of surgery for kidney cancer with Vena Cava Invasion. Eur Urol 2007; 52: 658-62 (Pubitemid 47126182)
17. Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR,. Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg 1989; 210: 387-92; discussion 392-4
18. Nesbitt JC, Soltero ER, Dinney CP, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 1997; 63: 1592-600 (Pubitemid 27321521)
19. Langenburg SE, Blackbourne LH, Sperling JW, et al,. Management of renal tumors involving the inferior vena cava. J Vasc Surg 1994; 20: 385-8 (Pubitemid 24294986)
20. Parekh DJ, Cookson MS, Chapman W, et al,. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol 2005; 173: 1897-902 (Pubitemid 40675206)
21. Boorjian SA, Sengupta S, Blute ML,. Renal cell carcinoma: vena caval involvement. BJU Int 2007; 99: 1239-44 (Pubitemid 46624170)
22. Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS,. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 2004; 171: 588-91 (Pubitemid 38090435)
23. Moinzadeh A, Libertino JA,. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 2004; 171: 598-601 (Pubitemid 38090438)
24. Haferkamp A, Bastian PJ, Jakobi H, et al,. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. J Urol 2007; 177: 1703-8 (Pubitemid 46560667)
25. Klaver S, Joniau S, Suy R, Oyen R, Van Poppel H,. Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b). BJU Int 2008; 101: 444-9 (Pubitemid 351160929)
26. Hudes G, Carducci M, Tomczak P, et al,. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356: 2271-81 (Pubitemid 46849157)
27. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115-24 (Pubitemid 46089672)
28. Motzer RJ, Escudier B, Oudard S, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 2008; 372: 449-56
29. Escudier B, Eisen T, Stadler WM, et al,. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125-34 (Pubitemid 46089673)